These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 16529836

  • 1. The use of recombinase mediated cassette exchange in retroviral vector producer cell lines: predictability and efficiency by transgene exchange.
    Coroadinha AS, Schucht R, Gama-Norton L, Wirth D, Hauser H, Carrondo MJ.
    J Biotechnol; 2006 Jul 13; 124(2):457-68. PubMed ID: 16529836
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene.
    Persons DA, Mehaffey MG, Kaleko M, Nienhuis AW, Vanin EF.
    Blood Cells Mol Dis; 1998 Jun 13; 24(2):167-82. PubMed ID: 9642098
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Construction and application of retroviral vector system useful for high-efficiency transfection into human T cells].
    Zhang RP, Yun L, Peng L, Lu B, Zhou Q, Wang H, Guo YJ.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul 13; 22(4):420-2, 426. PubMed ID: 16805997
    [Abstract] [Full Text] [Related]

  • 10. Reliable generation of stable high titer producer cell lines for gene therapy.
    Rattmann I, Kleff V, Feldmann A, Ludwig C, Sorg UR, Opalka B, Moritz T, Flasshove M.
    Intervirology; 2007 Jul 13; 50(3):197-203. PubMed ID: 17283445
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Transgene inheritance and retroviral infection contribute to the efficiency of gene expression in solid tumors inoculated with retroviral vector producer cells.
    Tamiya T, Wei MX, Chase M, Ono Y, Lee F, Breakefield XO, Chiocca EA.
    Gene Ther; 1995 Oct 13; 2(8):531-8. PubMed ID: 8593603
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Large-scale manufacturing of safe and efficient retrovirus packaging lines for use in immunotherapy protocols.
    Farson D, McGuinness R, Dull T, Limoli K, Lazar R, Jalali S, Reddy S, Pennathur-Das R, Broad D, Finer M.
    J Gene Med; 1999 Oct 13; 1(3):195-209. PubMed ID: 10738568
    [Abstract] [Full Text] [Related]

  • 17. Impact of retroviral vector components stoichiometry on packaging cell lines: effects on productivity and vector quality.
    Carrondo MJ, Merten OW, Haury M, Alves PM, Coroadinha AS.
    Hum Gene Ther; 2008 Feb 13; 19(2):199-210. PubMed ID: 18092921
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A convenient method for positive selection of retroviral producing cells generating vectors devoid of selectable markers.
    Xu L, Tsuji K, Mostowski H, Otsu M, Candotti F, Rosenberg AS.
    J Virol Methods; 2004 Jun 01; 118(1):61-7. PubMed ID: 15158069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.